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ABSTRACT 
Hypertension is the most pressing public health challenges. It is estimated that approximately 1 
billion people are suffering from high blood pressure and the numbers are to increase to 2.5 
billion by 2025. Raktachaapadhikya is the coined term for increased blood pressure given by 
recent authors where it can be understood as the pathology of Vyanvayu. The usage of 
Guduchyadi Yoga has been highlighted in the classics of Ayurveda for targeting the Hridaya 
sthitha vayu, which has not been evaluated yet. Aim: To evaluate and compare the efficacy of 
Navahridaya Kalpa (standard drug) and Guduchyadi Yoga (trial drug) for management of 
essential hypertension. Materials and Methods: A simple randomized controlled clinical study 
where 40 patients were equally divided as group A: Navahridaya kalpa (standard drug) and 
Group B: Guduchyadi yoga (trial drug) for a period of one month. Observations and results: 
The study result revealed that both the groups were beneficial in reducing high blood pressure 
however with no statistically significant difference found between the groups with p value 
being 0.339 for standard drug and 0.363 for trial drug. The group B was also found to be 
effective in reducing systolic blood pressure of stage I hypertension with p value .044 on 
comparing between the groups. Conclusion: The Guduchyadi yoga acts as Rasayana with the 
property of rejuvenation and antihypertensive which will check the high blood pressure at a 
very minimum cost without having any major adverse effects in the patients and hence can be 
advocated for use on a daily a basis. 
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INTRODUCTION 
Hypertension is one of the most alarming 
health problems of the present era. It is estimated 
that approximately 1 billion people worldwide are 
suffering from high blood pressure and its number is 
expected to increase to 2.5 billion by the year 2025.[1] 
Hypertension is known as the “Silent Killer” because 
typically it has no warning signs or symptoms, and 
many people do not know they have it even when 
blood pressure levels are dangerously high. 
Hypertension is of two types’ Essential Hypertension 
and Secondary Hypertension. About 90 to 95% of all 
people who have hypertension are said to have 
“Essential Hypertension” i.e. Primary or Idiopathic 
Hypertension.[2] In Ayurvedic classics, there is no 
reference for essential hypertension. The diagnosis is 
totally based on signs and symptoms of the disease 
elucidated by the physician, hence, from time to time 
various correlation has been made by recent authors 
and different names have been suggested for 
hypertension like co-relating it to Pittavruta udana, 
Raktagata vata, Pittavruta vata, Raktavruta vata, 
Vyan vayu vaishamyata. Raktachapadhikyata is the 
coined term which translates itself to as increase in 
the blood pressure.[3] Though there have been 
different opinions by different scholars, no one has 
denied the fact of essential hypertension of being 
psychosomatic in nature and Vata pradhana 
tridoshaja vyadhi. The ill-effects of faulty regimens 
like deviating from Dinacharaya, Ritucharya etc, 
influence the Rajodosha in Manas thus directly 
bringing out the Dosha vitiation in the Shareera so as 
it leads to an ailment which directly predisposes 
hypertension. 
MATERIALS AND METHODS 
Research design and study population: It was 
a simple randomized controlled clinical study having 
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two parallel arms (allocation ratio 1:1). The study 
population was composed of subjects diagnosed with 
Essential Hypertension which were selected from 
OPD, IPD and special camps conducted in Sri Sri 
College of Ayurvedic Science and Research Hospital, 
Bengaluru. The ethical clearance from the 
institutional ethical committee was obtained before 
the initiation of the research work. 
Eligibility Criteria 
Inclusion Criteria 
1. Subjects aged between 18-70yrs of either sex. 
2. Subjects falling under the category of stage-I and 
stage-II hypertension without underlying 
complications according to JNC-VIII updated 
guidelines of hypertension 
3. Subjects involving both fresh and treated cases of 
essential hypertension were selected. 
4. Subjects who were under Ayurvedic medicines 
were withdrawn for seven days and after the 
washout period, were included in the study. 
Exclusion Criteria 
1. Subjects below the age of 18 years and above 70 
years of age 
2. Subjects suffering from ischemic heart disease 
(IHD), Chronic kidney disease (CHD), Coronary 
artery disease (CAD), Coarctation of the aorta 
3. Subjects with secondary hypertension and 
gestational hypertension were excluded 
4. Subjects not willing to continue the treatment. 
Diagnostic Criteria 
 The diagnosis was made on the measurement 
of the blood pressure using a sphygmomanometer. 
The criteria for normal, pre-hypertension, 
hypertension stage I, and hypertension stage II was 
accepted by the report of the updated Joint National 
Committee (updated JNC-VIII)[4]. The measurement 
was made in all the three-position ex supine, sitting 
and standing. (Table no 1) 
Table 1: diagnostic JNC VIII criteria 
Cl. HTN SBP (mmHg) DBP(mmHg) 
N <120 <80 
Pre 120-139 80-89 
SI 140-159 90-99 
SII >160 >100 
Cl*.=Classification, HTN*.=Hypertension, SBP*.= 
Systolic blood pressure, DBP*.= Diastolic blood 
pressure, N*.= Normal, Pre*.= Prehypertension, 
SI*.=Stage I HTN, SII*.=Stage II HTN 
Intervention: 
Group A: Oral administration of Navahridaya kalpa 
(standard drug) 1 tablet three times a day for stage I 
HTN and 2 tablets thrice a day for stage II HTN with 
water as Anupana (drink after medication) for 30 
days. 
Group B: Oral administration of Guduchyadi yoga[5] 
(trial drug) 3 tablets weighing 3.25gm[6-7] collectively 
once a day for stage I HTN and twice a day for stage II 
HTN with hot water as Anupana (drink after the 
medication) for 30 days. 
Assessment Criteria 
Subjective Parameters 
1. Shiroshoola (Headache) 
2. Anidra (Sleeplessness) 
3. Hridravatva (Palpitation) 
4. Klama (Fatigue) 
5. Bhrama (Giddiness) 
Objective parameter 
 The disease primarily being asymptomatic, the 
measurement of blood pressure was considered as 
the primary parameter for assessment. The 
assessment was made with systolic, diastolic and 
mean arterial blood pressure. The measurement of 
blood pressure was made in all three postures 
namely, supine, sitting and standing. 
 The four assessments were made on the 7th, 
15th, 21st and 30th day of the trial period. The 
assessment was done with respect to the change in 
the blood pressure readings in all three positions and 
the mean of the three readings were recorded. 
Statistical Method: The results were analysed 
statistically, using the parametric tests like paired t-
test within the group, unpaired t-test between the 
group for objectives parameters and non-parametric 
tests like Mann Whitney test within the group, 
Wilcoxon test between the groups for subjective 
parameter with the help of SPSS software version 20. 
OBSERVATIONS 
 Among 40 patients who completed the study, 
maximum patients 16 in number i.e. 40% belonged to 
the age group 60-69 years, followed by the age group 
50-59 years and 40-49 years are 27% and 15% 
respectively, where as in 30-39 years is 5 i.e. 12.5% 
and in age group 20-29 are 2 i.e. 5% patients were 
registered. (Table 2) 
 There were 11 male patients contributing to 
55% and 9 female patients constituting 45% in Group 
A whereas there were 9 male patients constituting to 
45% and 11 female patients constituting 55% in 
Group B (Table 3). 
 The observation on the distribution of 
occupation revealed out of 40 patients, 26 patients 
were homemaker which constitute 65%, 8 patients 
were IT professional constituting 20%, 4 patients 
were in business constituting 10%, 2 patients were 
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student and employee constituting 2.5% each (Table 
no.4). 
 The study revealed that maximum patients 
i.e. 14 constituting 35% weighed between 70-79kgs, 
followed by 60-69 kgs constituting 10 (25%), 
patients weighing more than 80kgs were reported to 
be 9 in number constituting to 22.5% and 7 patients 
i.e. 17.5% in the range of 50-59 kgs. (Table no.5) Out 
of 40 patients majority i.e. 21 (52.5%) were freshly 
detected cases, 17 patients had a history from 
3months to one year constituting to (42.5%), and 2 
patients constituting to 5% had 1year-5years history. 
(Table no 6) 
Table 2: Showing the Incidence of Disease With Relation to Age 
Age (In years) Group A Group B Total 
20-29 0  2 2 (5%) 
30-39 4 1 5 (12.5%) 
40-49 6 0 6 (15%) 
50-59 4 7 11 (27%) 
60-69 6 10 16 (40%) 
Table 3: Showing the Incidence of Disease With Relation to Gender 
Gender Group A Group B Total 
Male 11 9 20 (50%) 
Female 9 11 20 (50%) 
Table 4: Showing the Incidence of Disease With Relation to Occupation 
Occupation Group A Group B Total 
IT professional 7 1 8 (20%) 
Homemaker 12 14 26 (65%) 
Business 1 3 4 (10%) 
Student 0 1 1 (2.5%) 
Service 0 1 1 (2.5%) 
Table 5: Showing the Incidence of Disease With Relation to Weight 
Weight (Kg) Group A Group B Total 
50-59 1 6 7 (17.5%) 
60-69 5 5 10 (25%) 
70-79 7 7 14 (35%) 
>80 7 2 9 (22.5%) 
Table 6: Showing the Incidence of Disease With Relation to Chronicity 
Chronicity Group A Group B Total 
Fresh 8 13 21 (52.5%) 
3months – 1 year 12 5 17 (14.5%) 
1 year-5year 0 2 2 (5%) 
5years and above 0 0 0 
RESULTS: A total of 44 subjects participated in the study. There were 4 dropouts who were lost to the 
followup. There were no patients in either groups with any adverse effects. 
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Allocated to controlled intervention (n=22) 
 N=20 received the standard drug 
 N=2 did not receive allocated  
interventionas they were lost to 
 follow up  
 
Allocation (1:1) 
Allocated to trial intervention (n=22) 
 N=20 received the trial drug  
 n=2 Did not receive allocated 
interventionas they were lost to 
follow up. 
Lost to follow-up n= 2  Lost to follow-up n= 2  
) Discontinued intervention n=0 Discontinued intervention n=0 
 
Analysed (n=20) 
 Excluded from analysis due to missing 
data (n=2) 
Analysed (n=20) 
 Excluded from analysis due to missing 
data (n= 2 ) 
Analysis 
Follow-Up 
Randomized (n=44) 
Excluded (n=0) 
 Not meeting inclusion criteria (n=0) 
 Declined to participate (n=0) 
 Other reasons (n=) 
 
Consecutively assessment of the Pre, stage I and 
II Hypertension subjects (as per JNC-8 
guidelines) age 18 to 70 years of age (n=44) 
Enrolment 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Fig.1 Consort diagram 
The results obtained regarding the subjective parameters were not statistically significant within the group for 
headache (Shiroshoola), however, due to decrease in the standard error and mean rank in group B than group 
A, implies that group B was better in relieving headache than group A. However, there was no statistically 
significant difference noted between the groups with p-value .690. (Table 7) 
Table 7: comparisons between groups 
Shiroshoola N Mean Sum of ranks P value 
Group A 5 6.00 30.00 .690 
Group B 5 5.00 25.00 
 There is no statistical significant value obtained for other subjective parameters like Anidra (Insomnia), 
Klama (Fatigue), Hridravatva (Palpitations) and Bhrama (Giddiness) owing to less sample size due to 
asymptomatic nature of the disease. 
 After analysing the statistical data with the help of paired t test within the group A and group B. The result 
was statistically found to be highly significant for systolic as well as diastolic blood pressure within the groups. 
(Table 8) 
Table 8: Comparisons Within the Groups 
Groups  N BT SD AT SD P-value 
Group A SBP 20 153.30 10.10 136.30 8.649 .000 
DBP 20 94.95 6.013 82.90 5.964 .000 
Group B SBP 20 153.70 5.048 143.45 12.98 .006 
DBP 20 93.80 6.646 85.00 6.821 .000 
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 The results observed on the stages of systolic and diastolic blood pressure considering the JNC VIII 
criteria it was found to be statistically highly significant for stage I of systolic blood pressure unlike the stage I 
of diastolic blood pressure within the group A and group B. (Table 9) 
Table 9: Comparisons within the Groups Based on the Stage of HTN 
 
 
 
 
 
 
 After analysing the data using unpaired t-test between the group A and group B for systolic and diastolic 
blood pressure, there was no significant difference found with p value as .339 for systolic blood pressure and 
.363 for diastolic blood pressure. However there was a significant difference observed for stage I systolic blood 
pressure between group A and B with p-value as 0.044. 
DISCUSSION 
 The incidence of HTN is seen more in the old 
age, which can be attributed to changes in decreased 
baroreceptor sensitivity, increased responsiveness to 
sympathetic nervous system stimuli, altered renal 
and sodium metabolism.[8] As already discussed 
about the Vata dosha pradhanata in the disease it can 
be inferred that with the increase in age, Vata dosha 
gets dominant therefore the old age people get more 
susceptible for Raktachapadhikyata or essential 
hypertension. In the present study, the exact ratio 
cannot be established due to small sample size, 
however, it was observed that both males and 
females are susceptible to essential hypertension/ 
Raktachapadhikyata. Despite the gender differences 
in human hypertension, the treatment guidelines do 
not differ by gender.[9] The study shows the majority 
of the patients were homemakers and IT 
professionals. The comprehensive reviews have 
concluded that the job strains, a combination of low 
control over the job and high psychological demands, 
is related to the incidence and prevalence of 
cardiovascular diseases. It was postulated that one of 
the underlying mechanisms through which job 
strains lead to cardiovascular disease and high blood 
pressure due to chronic psychological disorders.[10] 
There were a majority of the patients who were 
overweight in the present study where it again 
highlights the susceptibility of such patients to HTN. 
It is generally thought that the accumulation of 
visceral and ectopic fat in tissues and organs alters 
the metabolic and hemodynamic pathways leading to 
the development of hypertension in obese 
patients.[11] The main challenge in the diagnosis of 
essential hypertension is the absence of symptoms 
experienced by the patients. Hence it is termed as the 
‘Silent Killer’ as it goes on harming the body silently. 
The patient with essential hypertension is usually 
diagnosed on regular check-ups. Due to the absence 
of symptoms patients tend to ignore seeking medical 
help; hence lots of efforts are required to educate the 
mass about the incidence and prevalence of 
cardiovascular diseases. 
Discussion on Subjective Parameters 
 In the present study, among 40 patients who 
completed the study, both symptomatic and 
asymptomatic patients were registered. There were 
24 patients who presented with symptoms and the 
remaining 16 were asymptomatic (40%). The most 
common symptom which was observed in the 
patients was Shiroshoola (headache) with 16 patients 
constituting 40%. The other symptoms like Anidra 
(insomnia), Hridravatva (palpitation), Bhrama 
(giddiness) and Klama (fatigue) constituting 5% 
respectively. 
Shiroshoola (Headache): Both groups showed some 
improvement in the subjects with the symptoms. The 
changes were seen within the 7 days. The maximum 
effect was found on the 15th day and by the end of the 
30th day, six out of sixteen were relieved of the 
symptoms (Table 10-11). In group A, the drugs like 
Arjuna possess anti-spasmogenic property[12], 
Ashwagandha has the property of CNS depressant[13] 
and Brahmi acts as an anti-spasmodic drug which 
might help in relieving the headache to a 
considerable extent[14]. In group B, the Guduchi 
(Tinospora Cordifolia Thunb) and Maricha (Piper 
nigrum Linn) have the Rasayana properties hence act 
on the Vatadosha[15-16]. The potential therapeutic 
properties reported by modern scientific research 
includes it to have anti-oxidant, anti-stress 
properties.[17] 
Anidra (Insomnia): In group A, only two patients 
experienced moderate symptoms of Anidra 
(Insomnia). The result observed pre and post-
treatment reduced the moderate symptoms to mild 
symptoms. The result obtained might be due to the 
drugs like Sarpagandha[18] and Shankhapushpi which 
are Nidrajanaka, it also acts as a tranquilizer as 
studied through different researches. It acts as 
Medhya, Vrishya, and Rasayana and Manasarogahara. 
Groups  N BT SD AT SD P-value 
Group A SBP S1 10 149.60 2.50 140.20 9.40 .015 
DBP S1 4 93.25 3.77 90.00 .000 .184 
Group B SBP S1 10 150.40 2.50 145.60 4.76 .014 
DBP S1 4 93.25 3.77 90.75 1.50 .194 
Int. J. Ayur. Pharma Research,2020;8(7):13-20 
     Available online at: http://ijapr.in  18 
The glycoside of Shankhapushpi effects on lowering 
the blood pressure. According to Yogaratnakara it 
acts on Anidra and Bhrama.[19] Thus the Anidra 
(Insomnia) is relieved in the patient. 
Hridravatva (Palpitations): The patients in group A 
had a mild to moderate degree of the symptoms of 
Hridravatva (palpitations). The maximum effect of 
the treatment was seen on the 15th day and the 30th 
day, there was relief observed by the patient. The 
drug like Arjuna, which is considered as Hridya, 
regulates the Rakta vikshepana karma of heart and 
Ashwagandha reduces Chalaguna of Vata. In group B, 
there was only one patient with palpitations which 
was relieved by the end of the treatment. The 
probable action may be due to Guduchi (Tinospora 
Cordifolia Thunb.) along with Maricha (Piper nigrum 
Linn) has proven to have a positive impact on cardiac 
conditions such as angina pectoris, myocardial 
infarction, ischemic heart diseases and certain 
arrhythmias.[20] It might have helped clearing the 
obstruction in the arteries as well as in the heart and 
acted as cardio-protective agent. Thus Hridravatva 
(palpitations) was relieved. 
Bhrama (Giddiness): There was one patient in each 
group where the moderate symptom of Bhrama 
(giddiness) was reduced to absence of Bhrama 
(giddiness) by the end of the treatment in group A. 
The probable action might be due to the Rasayana 
effect of the drugs which act on Vata dosha. In group 
B the moderate symptom was reduced to mild 
symptom by the end of the treatment the result can 
be attributed to the Vata pitta hara and Medhya 
property[15-16], which might have impact the Mano 
dosha like Rajas. 
Klama (Fatigue): In group A, there was one patient 
where the moderate degree of Klama (fatigue) was 
reduced to absence of Klama (fatigue) by the end of 
the treatment where the action can be attributed to 
the various Rasayana and Balya properties of the 
drug in group A. In group B, the moderate symptom 
of Klama (fatigue) was reduced to mild symptom by 
the end of the treatment which can be attributed to 
the Rasayana property of the drugs as well as anti-
oxidant[15] and anti-stress[16] property. 
Discussion on Objective Parameters 
 In group A there was significant improvement 
seen with respect to systolic and diastolic blood 
pressure, the action of the drug can be attributed to 
the drugs like Sarpagandha, which is a proven drug 
acting on the vasomotor center directly leading to 
generalized vasodilatation further causing reduction 
in the blood pressure.[18] The main constituent i.e. 
reserpine also checks nausea. The other ingredient 
being Arjuna which acts on the Hridaya and is known 
to act as a hypotensive drug.[21] In group B also 
showed significant statistical result which can be 
attributed to the Guduchi (Tinospora Cordifolia 
Thunb.) which is known to be Tridosha shamaka and 
has cardio-tonic and hematopoietic activity and is 
effective in cardiac debility.[22] Guduchi (Tinospora 
Cordifolia Thunb.) is also known to have chromium 
with higher concentration of chromium in all the 
plants. It has been found that chromium plays a 
major role in ameliorating sucrose-induced blood 
pressure elevations and can act as antioxidant.[23] The 
constituents of stem of Guduchi (Tinospora Cordifolia 
Thunb.) are known as diterpenoid lactones which are 
known to have anti-hypertensive activities.[24] 
Similarly in Ayurveda it has been stated that the 
Shakha of Guduchi (Tinospora Cordifolia Thunb.) is 
accountable for Vatadosha pacification.[25] The 
studies have proved that piperine content of the 
Piper nigrum possess a blood pressure lowering 
effect mediated possibly through calcium channel 
blockade, while a consistent decrease in blood 
pressure.[15] It also helps in improving the 
bioavailability of the drug it is given along with, thus 
producing the synergic action of the drug over the 
body. 
Table 10: Showing the results of intervention on a subjective parameter in Group A 
 Grading Headache Insomania Palpation Fatigue Giddiness 
BT Severe 2 0 0 0 0 
Moderate 5 0 0 1 1 
Mild 0 0 1 0 0 
Absent 0 0 0 0 0 
Day 7 Severe 0 0 0 0 0 
Moderate 5 0 0 1 1 
Mild 2 0 1 0 0 
Absent 0 0 0 0 0 
DT 15 Severe 0 0 0 0 0 
Moderate 0 0 0 0 0 
Mild 7 0 1 0 1 
Absent 0 0 0 1 0 
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Day 22 Severe 0 0 0 0 0 
Moderate 0 0 0 0 0 
Mild 4 0 0 0 1 
Absent 3 0 1 1 0 
AT Severe 0 0 0 0 0 
Moderate 0 0 0 0 0 
Mild 5 0 0 1 1 
Absent 2 0 1 0 0 
Table 11: Showing the results of intervention on a subjective parameter in Group B 
 Grading Headache Insomania Palpation Fatigue Giddiness 
BT Severe 1 0 0 0 0 
Moderate 4 2 1 1 1 
Mild 4 0 1 0 0 
Absent 0 0 0 0 0 
Day 7 Severe 0 0 0 0 0 
Moderate 2 2 1 1 0 
Mild 6 0 1 0 0 
Absent 1 0 0 0 1 
DT 15 Severe 0 0 0 0 0 
Moderate 0 0 0 0 0 
Mild 5 2 1 1 0 
Absent 4 0 1 0 1 
Day 22 Severe 0 0 0 0 0 
Moderate 2 0 0 0 0 
Mild 4 2 1 1 1 
Absent 3 0 1 0 0 
AT Severe 0 0 0 0 0 
Moderate 1 0 0 0 0 
Mild 4 2 2 0 0 
Absent 4 0 0 0 1 
CONCLUSION 
 The study proved that both the drugs i.e. 
Navahridaya Kalpa (standard drug) and 
Guduchyadiyoga (trial drug) were beneficial in 
reducing the blood pressure with statistically 
significant values. The effect of both the drugs was 
found statistically significant on systolic blood 
pressure of the stage I hypertension. The main 
property mentioned for the Guduchyadi yoga being 
Rasayana i.e. having the property of rejuvenation and 
anti-hypertensive property will check the high blood 
pressure at a very minimum cost without having any 
major adverse effects in the patients. Guduchi 
(Tinospora Cordifolia Thunb.) and Maricha (Piper 
nigrum Linn) the two constituents of the Guduchyadi 
yoga are easily available and also Maricha (Piper 
nigrum Linn) also forms one of the main spices of 
every household in India. Hence the use of 
Guduchyadi yoga can be advised as alternative 
prescription in the daily regimen of the hypertensive 
patients. 
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